Tag: Motley Fool

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why EML, Jumbo, Mesoblast, and Whitehaven Coal shares are jumping today
• Why are Whitehaven Coal shares racing 7% higher on Friday?
• 5 things to watch on the ASX 200 on Friday
• Here are the top 10 ASX 200 shares today
• These ASX 200 shares just hit new 52-week highs

Motley Fool contributor Sebastian Bowen has positions in A2 Milk. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Lottery, Nanosonics, PEXA Group, Pro Medicus, and Xero. The Motley Fool Australia has positions in and has recommended Nanosonics and Xero. The Motley Fool Australia has recommended A2 Milk and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/v2kD3Z6

There are a large number of ASX dividend stocks to choose from on the Australian share market.

But which ones could be buys right now?

Three that have been given the thumbs up by brokers are listed below. Here’s what they are forecasting from them:

Baby Bunting Group Ltd (ASX: BBN)

The first ASX dividend stock that could be a buy for income investors is baby products retailer Baby Bunting.

The team at Morgans is feeling upbeat about the company’s outlook after a couple of years of struggles. In fact, it sees a return to growth on the horizon.

For example, it is forecasting fully franked dividends per share of 9.5 cents in FY 2024 and then 12.4 cents in FY 2025. Based on the current Baby Bunting share price of $1.82, this will mean dividend yields of 5.2% and 6.8%, respectively.

Morgans has an add rating and $2.50 price target on its shares.

Centuria Industrial REIT (ASX: CIP)

Another ASX dividend stock that has been given the thumbs up by analysts is Centuria Industrial.

It is largest domestic pure play industrial REIT with a 91% weighting to Australia’s high performing eastern seaboard industrial markets.

Macquarie is a fan of the company and is forecasting a result slightly ahead of guidance in FY 2024.

It expects this to underpin dividends per share of 16 cents in FY 2024 and 16.5 cents in FY 2025. Based on the current Centuria Industrial share price of $3.09, this represents yields of 5.2% and 5.3%, respectively.

The broker has an outperform rating and $3.41 price target on its shares.

Orora Ltd (ASX: ORA)

Finally, Goldman Sachs think this packaging company would be a good ASX dividend stock to buy.

The broker likes that Orora’s base business has defensive qualities and is positive on growth capital investments. In addition, it feels the current market implied valuation of the Saverglass business provides a favourable risk-reward skew.

As for income, its analysts are forecasting dividends per share of 14 cents in FY 2024, 15 cents in FY 2025, and 16 cents in FY 2026. Based on the current Orora share price of $2.63, this will mean yields of 5.3%, 5.7%, and 6.1%, respectively.

Goldman has a buy rating and $3.50 price target on its shares.

The post Analysts say these 3 ASX dividend stocks are buys with big yields appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 3 ASX dividend stocks to boost your income portfolio in 2024
• Here are the top 10 ASX 200 shares today
• Buy Coles and these ASX dividend stocks
• These ASX dividend stocks could be buys this month
• Where I’d invest $3,000 into ASX dividend shares in January

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Orora. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/9ITw0XN

ASX All Ords healthcare share Imugene Limited (ASX: IMU) is up 10% on Friday to 11 cents.

The share price bump follows another update from the clinical-stage immuno‐oncology biotech company, which is developing virotherapies to treat and kill cancer.

What news does this ASX All Ords biotech have today?

On Friday, Imugene released a second update for the week on its Phase 1 MAST (Metastatic Advanced Solid Tumours) trial.

The trial is evaluating the safety and efficacy of Imugene’s novel cancer-killing virus CF33-hNIS (Vaxinia).

Today we learned that the first patients in the Phase 1 study’s higher dose cohort have received their dose.

On Wednesday, the ASX All Ords company reported early positive signals in the trial, which sent its share price soaring 14%.

Imugene said 38 patients had been dosed with Vaxinia during the continuing dose escalation phase.

Of them, 31 had undergone their first scans after 42 days to see the results.

In the IT cohorts comprising 14 patients, seven of the 15 cancer lesions injected with Vaxinia had reduced in size, and three were eradicated.

The CEO of Imugene, Leslie Chong, said:

Following the positive news on VAXINIA’s early signals and FDA Fast Track Designation to end 2023, we are pleased to start the new year by announcing the ongoing progress of the MAST trial as we continue to see no safety issues with the drug.

We also look forward to expanding the trial to take a closer look at bile duct cancer where we’ve seen early encouraging results.

Imugene gave a poster presentation on Vaxinia for the treatment of gastrointestinal (GI) malignancies at the annual ASCO Gastrointestinal Cancers Symposium (ASCO-GI) in San Francisco, California today.

The presentation contained preliminary data from the first three dose levels in the MAST study.

The company said the data demonstrated encouraging anti-tumor activity with Vaxinia monotherapy.

This included one patient who achieved an immunological complete response with no known recurrence after one year.

Imugene told attendees that Vaxinia “may be an effective and safe treatment option for GI malignancies …”.

The company also said Vaxinia warrants further investigation in biliary tract cancer patients.

Imugene share price snapshot

This ASX All Ords healthcare share has fallen 33% over the past 12 months.

Over the same time period, the S&P/ASX 200 Health Care Index (ASX: XHJ) has retreated 1.23%.

The post This ASX All Ords healthcare share is leaping 10% on cancer-killing drug trial progress appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why Data#3, Deep Yellow, DroneShield, and Imugene shares are racing higher today
• Why is ASX 300 healthcare stock Imugene jumping 14% today?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/p3E5KTI

It’s been a much-needed happy day for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares so far this Friday. The ASX 200 is presently up by a rosy 0.99% to back over 7,400 points. However, if we look at the Deep Yellow Ltd (ASX: DYL) share price, it seems these gains have not extended to ASX uranium shares.

While the ASX is riding high, Deep Yellow shares are sinking. The uranium producer is currently down a nasty 4.97% to $1.49 a share.

Other ASX uranium shares are suffering too. Boss Energy Ltd (ASX: BOE) is nursing a loss of 2.5%, and Paladin Energy Ltd (ASX: PDN) is down 2.4%.

But Deep Yellow seems to be getting singled out here. So what’s going on?

Why is the Deep Yellow share price tanking on Friday?

To clear this up, there’s been no official news or ASX announcements out of Deep Yellow itself today.

However, we still might be able to work out what might be going on.

According to a report in the Australian Financial Review (AFR) this week, ASX broker Bell Potter has recently been attempting to set up meetings between Deep Yellow and investors. However, those meetings were subsequently cancelled by Deep Yellow after it was speculated that they could be preceding a new capital raise program.

The Deep Yellow share price has exploded higher over the past 12 months, rising close to 100%. So it makes sense that Deep Yellow might want to take advantage of this situation with a new capital raising program.

However, the report notes that the explosive runup for Deep Yellow shares has also attracted short-seller interest. As such, a new capital raise, or even rumours of one, could embolden these shorters (capital raises normally result in a drop in share price).

As such, it’s possible that this is what is putting a dampener on the Deep Yellow share price this Friday. Considering Deep Yellow’s recent share price performance though, it probably won’t bother too many investors.

The post Why is the Deep Yellow share price missing out on today’s market rally? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why Avita Medical, Deep Yellow, Piedmont Lithium, and Syrah shares are falling today
• Why Data#3, Deep Yellow, DroneShield, and Imugene shares are racing higher today
• I’d invest in these 2 ASX shares for a real shot at $1 million
• The shocking admission catapulting ASX uranium shares to record highs today
• Why Bapcor, Deep Yellow, Super Retail, and Telstra shares are rising today

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Jyj41Kp

Over the past months, Flight Centre Travel Group Ltd (ASX: FLT) shares have often found themselves among the 10 most shorted shares on the ASX.

And this week is no exception.

The S&P/ASX 200 Index (ASX: XJO) travel stock kicked off the week as the ninth most shorted share on the ASX, with 8.9% of its shares held short.

Depending on their timing, of course, some short sellers may or may not have made money betting against Flight Centre.

But it certainly doesn’t look like they will this week.

As of last Friday’s close, Flight Centre stock is up 1.8%, currently trading for $20.85 a share.

As for the past 12 months, here’s what I’d have today if I’d invested $10,000 in Flight Centre a year ago.

How have Flight Centre shares performed over the year?

On 19 January 2023, the ASX 200 travel stock closed the day trading for $15.86.

That means I could have snapped up 630 shares, with enough change left over for a pint of beer.

As mentioned above, in afternoon trade today shares are trading for $20.85. Meaning my 630 Flight Centre shares would be worth $13,135.50. Or a handy gain of $3,135.50 from my $10,000 investment a year ago.

But let’s not forget the welcome return of the company’s fully franked dividends, paid out on 19 October.

While not very large at 18 cents per share, Flight Centre paid its first dividend this year since 2019. The dividends were then derailed by the outbreak of the global pandemic.

If we add those dividends back in then the accumulated value of my Flight Centre stockholdings equates to $13,248.90.

That’s a 32.5% gain in 12 months.

Short sellers, take note.

What now?

Despite the strong short interest in Flight Centre shares, Morgans analysts remain quite optimistic about the company’s outlook.

In late December, the broker had an ‘add’ rating on the stock with a $26 price target.

That’s almost 25% above the current price.

The post If I’d invested $10,000 in Flight Centre shares a year ago here’s what I’d have now! appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• These are the 10 most shorted ASX shares
• 3 ASX growth shares to buy to supercharge your portfolio
• These are the 10 most shorted ASX shares
• These are the 10 most shorted ASX shares
• Big returns could be coming for these ASX 200 growth shares in 2024

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/liF3Dmo

ANZ Group Holdings Ltd (ASX: ANZ) shares have set a new 52-week high on Friday at $26.12.

The ANZ share price is currently $26.00, up 0.81%, while the S&P/ASX 200 Index (ASX: XJO) is up 0.9%.

There is no official news from ANZ today.

The ASX bank share is currently awaiting the outcome of its appeal against the Australian Competition and Consumer Commission’s (ACCC) decision to block its merger with the banking division of Suncorp Group Ltd (ASX: SUN).

ANZ applied for a review of the ACCC’s decision by the Australian Competition Tribunal in August 2023.

As reported by Reuters, top broker Citi has put out a note on Suncorp saying the sale of its banking unit is “more likely to occur than not”.

Citi says it expects solid revenue growth for Suncorp due to interest rate increases over the past six months.

However, it also expects 1H FY24 net interest margins to be lower than forecasted due to an “intensely competitive environment”.

Citi has raised its 12-month share price target on Suncorp shares to $15.55.

The Suncorp share price is currently $14.01, up 0.21% for the day.

ANZ share price snapshot

ANZ shares have lifted 4.5% over the past 12 months, while Suncorp shares have risen 13.35%.

The post ANZ shares breach 52-week record amid merger expectations appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Brokers name 3 ASX shares to buy now
• 5 things to watch on the ASX 200 on Friday
• Brokers say these high-yield ASX dividend shares are buys
• What will my ASX 200 bank stocks be worth in 5 years?
• How much would I need to invest in ANZ shares for $7,000 a year in passive income?

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Bronwyn Allen has positions in Anz Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/e8p7xSm

APM Human Services International Ltd (ASX: APM) shares are rebounding today but only slightly — up 2.8% to 81 cents. Meantime, the S&P/ASX 200 Index (ASX: XJO) is up 0.9%.

The international employment services company was thrashed by the market yesterday after releasing its 1H FY24 update after the market close on Wednesday.  

APM reported preliminary unaudited revenue of $1.14 billion for the six months ended 31 December, up from $853.7 million in 1H FY23.

However, its underlying NPATA plummetted 35% from $85.4 million in 1H FY23 to $55 million in 1H FY24.

Investors delivered a walloping to APM shares yesterday, with the share price falling 40%.

APM shares spiralled to an all-time low of 79 cents and a closing value of 80 cents.

This is a stunning turn of events for the company, which was only listed a little over two years ago at $3.55 per share. The chart below documents the decline of the APM share price.

The company said the weak first-half performance was due to continuing low unemployment.

This meant reduced client flows into employment services programs and fewer job placements, especially in Australia and the United Kingdom. It also cited higher interest rates and taxes.

APM expects things to improve in 2H FY24, noting that a second-half skew is consistent with prior reporting periods.

APM’s update comes amid the sixth consecutive quarterly fall in job vacancies in Australia.

The unemployment rate is also steadying at 3.9% for both November and December.

David Taylor, head of labour statistics at the Australian Bureau of Statistics (ABS), said:

In trend terms, many of the key indicators still point to a tight labour market.

However, the increasing unemployment rate since November 2022, along with the rising underemployment rate and slowdown in the growth of employment and hours worked, suggest that the labour market is starting to slow.

The post APM shares rebound on Friday following 40% thrashing on weaker profit news appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why Ampol, APM, Liontown, and Wildcat shares are dropping today
• Guess which ASX All Ords shares are sinking after poor updates

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended APM Human Services International. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/jDRFvpV

The rise of artificial intelligence (AI) will arguably benefit many ASX shares. But there’s one ASX exchange-traded fund (ETF) that might be first in line to rake in some of AI’s transformative upside.

The BetaShares Global Cybersecurity ETF (ASX: HACK) is a popular choice for many ASX investors. It’s an ETF that specialises in providing exposure to the cybersecurity industry, and the most important players within it.

But it could also be poised to prosper from the rise of AI.

ASX ETF to benefit from the rise of AI cyberattacks

A recent report from NBC revealed the rising use of AI tools like ChatGPT by hackers to produce fraudulent emails, cyberattacks and criminal schemes.

The report quotes the United States National Security Agency (NSA)’s director Rob Joyce, who stated the following:

We already see criminal and nation-state elements utilizing AI,” he said. “We’re seeing intelligence operators, we’re seeing criminals on those platforms… One of the first things they’re doing is they’re just generating better English-language outreach to their victims, whether it’s phishing emails or something much more elaborative in the case of malign influence.

However, Joyce also argued that AI technology is being employed to help defend against cyberattacks and hacking. The NSA has recently announced the creation of an AI Security Centre to promote the “secure adoption of new AI capabilities” across the cybersecurity world.

Joyce stated that “AI machine learning, deep learning, is absolutely making us better at finding malicious activity. It is helping us see things illuminated so it stands out from the norm”.

And that brings us back to the BetaShares Global Cybersecurity ETF. This ETF holds many companies that are at the forefront of the fight against cybercrime. These include Broadcom, Crowdstrike, Palo Alto, Okta and Zscaler.

To illustrate, access management stock Okta is currently developing Okta AI. Using Okta AI can reportedly lead to a 90% reduction in bot activities over 90 days.

Another cybersecurity stock, Crowdstrike, is also harnessing the power of AI to “detect the most advanced threats while minimizing false positives”. The company’s “world-class AI” is reportedly “trained on trillions of security events from a variety of platforms”.

So while the rise of AI has led to new challenges in the cybersecurity front, it is also opening up new solutions in the fight against online illegal activity. And this ETF can help investors get a slice of the action.

The post Could AI be a boon for this ASX ETF? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 2 excellent ASX ETFs I’d buy for diversification and growth
• 3 ASX ETFs for growth investors to buy in January
• Got a lot of cash? Here’s why I’d start investing it in ASX shares in 2024
• How I’d kick-start my children’s financial future with ASX shares under the Christmas tree

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended BetaShares Global Cybersecurity ETF, CrowdStrike, Okta, Palo Alto Networks, and Zscaler. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Broadcom. The Motley Fool Australia has positions in and has recommended BetaShares Global Cybersecurity ETF. The Motley Fool Australia has recommended CrowdStrike and Okta. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/bgpkWQc

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 0.9% to 7,412 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are falling:

AVITA Medical Inc (ASX: AVH)

The AVITA Medical share price is down 3% to $4.23. This is despite there being no news out of the regenerative medicine company. However, prior to today, its shares were up 20% in the space of a month. This could mean that some investors are taking a bit of profit off the table on Friday.

Deep Yellow Limited (ASX: DYL)

The Deep Yellow share price is down over 3% to $1.52. This appears to have been driven by concerns that the uranium developer is about to raise capital. According to the AFR, the company cancelled meetings with institutional investors after being contacted by the media outlet.

Piedmont Lithium Inc (ASX: PLL)

The Piedmont Lithium share price is down 1% to 28.7 cents. This morning, this lithium miner announced an agreement to sell some of its Atlantic Lithium Ltd (ASX: A11) shares to Assore International. A total of 24.3 million shares in Atlantic are being sold for 25 British pence per share to raise US$7.8 million. Investors appear disappointed that it is selling the shares at such low levels rather than waiting for a rebound.

Syrah Resources Ltd (ASX: SYR)

The Syrah share price is down 3% to 41 cents. This is despite there being no news out of the graphite producer. However, it is worth noting that its shares have been under significant pressure over the last 12 months. So much so, they hit a 52-week low this morning.

The post Why Avita Medical, Deep Yellow, Piedmont Lithium, and Syrah shares are falling today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why Data#3, Deep Yellow, DroneShield, and Imugene shares are racing higher today
• I’d invest in these 2 ASX shares for a real shot at $1 million
• The shocking admission catapulting ASX uranium shares to record highs today
• Why Bapcor, Deep Yellow, Super Retail, and Telstra shares are rising today
• These are the 10 most shorted ASX shares

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical. The Motley Fool Australia has recommended Avita Medical. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/ameHk86

The S&P/ASX 200 Index (ASX: XJO) is well and truly back on form on Friday. In morning trade, the benchmark index is up 1% to 7,420.2 points.

Four ASX shares that are rising more than most today are listed below. Here’s why they are jumping:

EML Payments Ltd (ASX: EML)

The EML Payments share price is up a further 9% to 99 cents. Investors have been buying this payments company’s shares this week after it announced plans to close down its loss-making PFS Card Services Ireland business. Management advised that it will now be closed to new business and wound down in a professional and orderly manner.

Jumbo Interactive Ltd (ASX: JIN)

The Jumbo Interactive share price is up 6% to $14.77. This appears to have been driven by news that the next Powerball jackpot will be the second largest in history at $150 million. This will be good news for this lottery ticket seller, which clips the ticket on each sale through its platform.

Mesoblast Ltd (ASX: MSB)

The Mesoblast share price is up 16% to 30.75 cents. Investors have been fighting to buy the biotechnology company’s shares today after it was given some positive news from the US FDA. The regulator has granted its allogeneic cell therapy Revascor (rexlemestrocel-L) a Rare Pediatric Disease Designation. This follows the submission of results from the randomised controlled trial in children with hypoplastic left heart syndrome, which is a potentially life-threatening congenital heart condition.

Whitehaven Coal Ltd (ASX: WHC)

The Whitehaven Coal share price is up over 5% to $8.23. This morning, this coal miner released its second quarter update. While managed run-of-mine (ROM) production came in 6% lower quarter on quarter at 5.0Mt, the company reported a 21% increase in total equity sales of produced coal to 3.7Mt for the three months.

The post Why EML, Jumbo, Mesoblast, and Whitehaven Coal shares are jumping today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why are Whitehaven Coal shares racing 7% higher on Friday?
• Why are Mesoblast shares rocketing 28% today?
• Why EML, Mount Gibson, Nuix, and Raiz shares are rising today
• Why is the EML share price rocketing 27% on Thursday?
• Why Alumina, Jumbo, Kali Metals, and Silex shares are pushing higher today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended EML Payments and Jumbo Interactive. The Motley Fool Australia has recommended Jumbo Interactive. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/OAkLx54